Publication Details

Phase II study evaluating oral triamcinolone in patients with androgen-independent prostate cancer.

Srinivas S, Krishnan AV, Colocci N, Feldman D. Urology. 2006; 67 (5): 1001-6

To assess the effect of triamcinolone administration on the serum prostate-specific antigen (PSA) response and the time to progression in patients with androgen-independent prostate cancer (AIPC).

PubMedID: 16698360